Results 61 to 70 of about 37,681 (214)

Prior Authorization for Sacral Nerve Stimulation in the Era of WISeR: Evaluation of U.S. Payer Coverage Policies

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Sacral nerve stimulation (SNS) is an established therapy for refractory urinary incontinence, yet the 2025 Wasteful and Inappropriate Service Reduction Model (WISeR) designated it as requiring mandatory prior authorization. No analysis has examined how U.S.
Thriaksh Rajan, Andre Revnew, David Sheyn, Adonis Hijaz, Ramy Abou Ghayda   +4 more
wiley   +1 more source

Physiological variables and molecular study of KLK2 and KLK3 among patient with benign prostatic hyperplasia

Alexandria Journal of Medicine, 2018
Prostatic hyperplasia is benign tumor occur in prostate. Benign prostatic hyperplasia is common disease in old men. The incidence of disease arises with increase in age.
Mustafa F. Dawood, Sameer M. Khalaf, Ahmed A. Suleiman   +2 more
doaj   +1 more source

Zeroing Pressures in Urodynamics: Revisiting Current Practice and Pressure Interpretation

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Zeroing of pressure transducers is a fundamental step in urodynamic testing, as it affects pressure tracings and numerical values. Atmospheric zeroing before catheter insertion is the recommended approach, but zeroing with catheters in situ is also used.
Lucas Antonio Pereira do Nascimento, Vicktor Bruno Pereira Pinto, Carlos Henrique Costa, Cristiano M. Gomes   +3 more
wiley   +1 more source

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

Obesity, EarlyView.
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu, Hao Dai, Huilin Tang, William T. Donahoo, Thomas J. George, Ramon C. Sun, Sizun Jiang, Aik Choon Tan, Yi Guo, Jonathan D. Licht, John M. Allen, Kelvin P. Lee, Jingchuan Guo, Jiang Bian   +13 more
wiley   +1 more source

The impact of open benign prostatic hyperplasia surgery on erectile function in patients with benign prostatic hyperplasia, Northeast Ethiopia, 2023.

Medicine Science
Background: It was believed that surgical treatments for benign prostatic hyperplasia could improve erectile function due to the relief of symptoms they were also reported to harm erectile function as heating or injury effect.
Leul Mekonnen Zeru, Mekuriaw Wuhib Shumye, Mitaw Girma Kembaw, Zemen Mengesha Yalew, Getachew Wuhib, Melatwork Assefa, Hailemaryam Shiferaw, Belachew Tegegne Shiferaw   +7 more
doaj   +1 more source

Immune dysregulation in the prostates of C57BL/6Aire−/− mice mirrors that seen in human benign prostatic hyperplasia

The Journal of Pathology, EarlyView.
Abstract Benign prostatic hyperplasia (BPH) is the most common urologic disease in aging men, resulting in significant morbidity. The etiologies of BPH are unknown, though chronic prostatic inflammation is known to promote hyperplasia, fibrotic remodeling, and therapeutic resistance in BPH.
Nadia A Lanman, Meaghan M Broman, Harish Kothandaraman, Gregory M Cresswell, Gada D Awdalkreem, Dilinaer Wusiman, Andree K Kolliegbo, Alexander P Glaser, Brian T Helfand, Renee E Vickman, Jiang Yang, Simon W Hayward, Timothy L Ratliff   +12 more
wiley   +1 more source

Algorithm for a short course of finasteride in patients with benign prostatic hyperplasia before transurethral resection of the prostate

Медицинский совет, 2014
Benign prostatic hyperplasia (BPH), for a long time known as benign prostatic hypertrophy, is so widespread that many researchers say, it inevitably occurs in men who have lived long enough for BPH to develop.
KB Kolontarev, GR Kasyan
doaj   +1 more source

A Simple Cell Culture Assay for Human Prostatic Branching Morphogenesis Spotlights Bone Morphogenetic Protein Signaling as a Therapeutic Target in Benign Prostatic Hyperplasia

The Prostate, EarlyView.
ABSTRACT Background Benign prostatic hyperplasia (BPH) leads to prostate enlargement and lower urinary tract symptoms that can resist treatment. A histologic hallmark of BPH is glandular epithelial hyperplasia with new ductal branching morphogenesis. The stromal inductive factors driving tissue morphogenesis may provide new therapeutic targets, but are
Anna S. Pollack, James D. Brooks, Jonathan R. Pollack   +2 more
wiley   +1 more source

Role of prostatic artery embolization in management of symptomatic benign prostatic hyperplasia

The Egyptian Journal of Radiology and Nuclear Medicine, 2016
Objectives: To assess the feasibility and efficacy of prostatic artery embolization in relieving symptoms of benign prostatic hyperplasia. Materials and methods: In a prospective study 28 patients with symptomatic benign prostatic hyperplasia were ...
Mohamed Shaker, Karim A. Abd El Tawab, Khaled H. Abd El Tawab, Mohamed El-Gharib   +3 more
doaj   +1 more source

Predictive Value of [−2]proPSA‐Related Indices for Prostate Cancer Detection Years Before Prostate‐Specific Antigen Elevation: Insights From a Five‐Year Longitudinal Screening Cohort

The Prostate, EarlyView.
ABSTRACT Background [‐2]proPSA(p2PSA)‐related indices have demonstrated diagnostic value for detecting prostate cancer (PC) in males with modest increases in prostate‐specific antigen levels (PSA) of < 10 ng/mL. However, the “leak point” of p2PSA level in the blood circulation before developing screen‐detectable PC remains uncertain.
Yoshitaka Sekine, Yuji Fujizuka, Syun Nakazawa, Yusuke Tsuji, Akira Ohtsu, Yoshiyuki Miyazawa, Seiji Arai, Masashi Nomura, Hidekazu Koike, Hiroshi Matsui, Kazuto Ito, Kazuhiro Suzuki   +11 more
wiley   +1 more source